首页> 美国卫生研究院文献>International Journal of Molecular Sciences >Design Synthesis and Biological Evaluation of Biphenylglyoxamide-Based Small Molecular Antimicrobial Peptide Mimics as Antibacterial Agents
【2h】

Design Synthesis and Biological Evaluation of Biphenylglyoxamide-Based Small Molecular Antimicrobial Peptide Mimics as Antibacterial Agents

机译:基于联苯基甲酰胺基小分子抗微生物肽模拟物的设计合成及生物学评价作为抗菌剂

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

There has been an increasing interest in the development of antimicrobial peptides (AMPs) and their synthetic mimics as a novel class of antibiotics to overcome the rapid emergence of antibiotic resistance. Recently, phenylglyoxamide-based small molecular AMP mimics have been identified as potential leads to treat bacterial infections. In this study, a new series of biphenylglyoxamide-based small molecular AMP mimics were synthesised from the ring-opening reaction of N-sulfonylisatin bearing a biphenyl backbone with a diamine, followed by the conversion into tertiary ammonium chloride, quaternary ammonium iodide and guanidinium hydrochloride salts. Structure–activity relationship studies of the analogues identified the octanesulfonyl group as being essential for both Gram-positive and Gram-negative antibacterial activity, while the biphenyl backbone was important for Gram-negative antibacterial activity. The most potent analogue was identified to be chloro-substituted quaternary ammonium iodide salt 15c, which possesses antibacterial activity against both Gram-positive (MIC against Staphylococcus aureus = 8 μM) and Gram-negative bacteria (MIC against Escherichia coli = 16 μM, Pseudomonas aeruginosa = 63 μM) and disrupted 35% of pre-established S. aureus biofilms at 32 μM. Cytoplasmic membrane permeability and tethered bilayer lipid membranes (tBLMs) studies suggested that 15c acts as a bacterial membrane disruptor. In addition, in vitro toxicity studies showed that the potent compounds are non-toxic against human cells at therapeutic dosages.
机译:对抗微生物肽(AMPS)的发展越来越令人兴趣,它们作为一种新型抗生素的合成模拟,以克服抗生素抗性的快速出现。最近,已经鉴定了苯基甲酰胺的小分子放大器模拟物作为治疗细菌感染的潜在导致。在该研究中,通过载入二苯基骨架的N-磺酰基状素的开环反应合成了一种新的联苯基氧酰胺基小分子amp模拟物,然后用二胺进行转化为叔氯化铵,季铵碘化铵和盐酸胍盐。类似物的结构 - 活性关系研究将辛烷磺酰基鉴定为革兰氏阳性和革兰氏阴性抗菌活性,而联苯基骨架对于革兰氏阴性抗菌活性至关重要。最有效的类似物被鉴定为氯取代的季铵碘化盐15c,其具有针对革兰氏阳性(麦克风=8μm)和革兰氏阴性细菌的抗菌活性(麦克风=大肠杆菌=16μm,假单胞菌(Pseudomonas)铜绿假单胞菌=63μm)并在32μm中扰乱了35%的预先成立的S.UUREUS生物膜。细胞质膜渗透性和束缚双层脂质膜(TBLMS)研究表明,15C作为细菌膜破坏器。此外,在体外毒性研究表明,在治疗剂量下,有效的化合物对人体细胞无毒。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号